Amprius Technologies, Inc.
AMPX NYSE Miscellaneous Electrical Machinery, Equipment & Supplies Financials FY2021βFY2025
What Amprius Technologies, Inc. does
No business description yet.
- Legal name
- Amprius Technologies, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 6, 2026
- Accession Β· CIK
- 0001899287-26-000015
0001899287
Revenue and margins
Amprius Technologies, Inc. had $73.0M of revenue in fiscal 2025, up 202.1% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$35.5M in fiscal 2025, β48.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Amprius Technologies, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 22.3%.
Balance sheet
Cash, debt and the ratios that show how comfortably Amprius Technologies, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $11.5M | $69.7M | $45.8M | $55.2M | $90.5M |
| Current ratio | 3.4x | 10.9x | 3.8x | 4.0x | 7.1x |
| Quick ratio | 3.3x | 10.8x | 3.7x | 3.6x | 6.7x |
| Total assets | $18.5M | $83.2M | $108M | $121M | $157M |
| Total liabilities | $4.7M | $10.1M | $47.9M | $51.7M | $53.1M |
| Shareholders' equity | $13.9M | $73.0M | $59.8M | $69.5M | $104M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β |
| F-score | β / 3 | 4 / 8 | 2 / 8 | 4 / 8 | 5 / 8 |
| Accruals ratio | β10.1% | β6.8% | β11.8% | β9.9% | β9.3% |
| Altman Z'' | β10.46 | 7.85 | β2.77 | β3.05 | 0.06 |
5 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $2.8M | $4.4M | $9.1M | $24.2M | $73.0M |
| Gross profit | β$4.3M | β$5.7M | β$14.7M | β$18.3M | $8.3M |
| Research and development | $1.5M | $2.0M | $3.7M | $7.3M | $9.4M |
| Operating income | β$10.6M | β$18.0M | β$38.7M | β$46.3M | β$46.6M |
| Pretax income | β$9.9M | β$17.3M | β$36.8M | β$44.7M | β$44.0M |
| Income tax | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net income | β$9.9M | β$17.3M | β$36.8M | β$44.7M | β$44.0M |
| Net income to common | β$9.9M | β$17.3M | β$36.8M | β$45.4M | β$44.0M |
| Diluted EPS | β$0.15 | β$0.24 | β$0.43 | β$0.45 | β$0.35 |
| Diluted shares | 0.07B | 0.07B | 0.09B | 0.10B | 0.12B |
| Cash flow | |||||
| Cash from operations | β$8.0M | β$13.9M | β$25.6M | β$33.4M | β$31.1M |
| Capital expenditure | $0.6M | $1.5M | $17.6M | $3.2M | $4.4M |
| Free cash flow | β$8.6M | β$15.4M | β$43.1M | β$36.6M | β$35.5M |
| Depreciation and amortization | $1.4M | $1.5M | $1.8M | $3.8M | $4.4M |
| Stock-based compensation | $2.5M | $2.7M | $3.9M | $7.3M | $7.4M |
| Balance sheet | |||||
| Cash and short-term investments | $11.5M | $69.7M | $45.8M | $55.2M | $90.5M |
| Current assets | $14.2M | $75.2M | $50.5M | $68.8M | $126M |
| Current liabilities | $4.2M | $6.9M | $13.5M | $17.2M | $17.9M |
| Inventory | $0.5M | $0.5M | $0.7M | $6.6M | $6.7M |
| Property and equipment, net | $4.2M | $4.2M | $21.8M | $17.5M | $9.7M |
| Total assets | $18.5M | $83.2M | $108M | $121M | $157M |
| Total liabilities | $4.7M | $10.1M | $47.9M | $51.7M | $53.1M |
| Shareholders' equity | $13.9M | $73.0M | $59.8M | $69.5M | $104M |
| Margins | |||||
| Gross margin | β156.2% | β128.2% | β162.1% | β75.8% | 11.3% |
| Operating margin | β383.2% | β409.2% | β427.6% | β191.4% | β63.9% |
| EBITDA margin | β331.2% | β374.3% | β407.6% | β175.7% | β57.9% |
| Net margin | β357.0% | β393.1% | β406.2% | β184.8% | β60.3% |
| FCF margin | β311.1% | β348.4% | β476.1% | β151.3% | β48.7% |
| Returns | |||||
| Return on capital employed | β74.0% | β23.7% | β41.1% | β44.5% | β33.6% |
| Return on equity | β71.4% | β39.9% | β55.4% | β69.1% | β50.8% |
| Return on assets | β53.4% | β34.1% | β38.5% | β39.0% | β31.7% |
| Return on tangible equity | β71.4% | β23.7% | β61.5% | β65.3% | β42.4% |
| Growth | |||||
| Revenue growth | β | 59.1% | 105.3% | 167.0% | 202.1% |
| Share count change | β | 8.5% | 20.8% | 18.2% | 22.3% |
| Financial health | |||||
| Current ratio | 3.4x | 10.9x | 3.8x | 4.0x | 7.1x |
| Quick ratio | 3.3x | 10.8x | 3.7x | 3.6x | 6.7x |
| Capital allocation | |||||
| Capex / revenue | 22.0% | 33.6% | 193.9% | 13.3% | 6.0% |
| Stock comp / revenue | 89.2% | 61.4% | 42.9% | 30.4% | 10.1% |
| Quality scores | |||||
| Piotroski F-score | β | 4.0 | 2.0 | 4.0 | 5.0 |
| Altman Z'' | β10.5 | 7.8 | β2.8 | β3.1 | 0.1 |
| Accruals ratio | β10.1% | β6.8% | β11.8% | β9.9% | β9.3% |
Source: SEC EDGAR XBRL filings (CIK 0001899287). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.